We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Capital One
COF
$137B
| $4.28M | 0.02% |
39,105
-404,529
| -91% | -$40.5M |
|
727
News Corp Class B
NWS
$17.8B
| $4.27M | 0.02% |
216,509
+26,958
| +14% | +$493K |
|
728
GATX Corp
GATX
$6.33B
| $4.27M | 0.02% |
33,163
+23,313
| +237% | +$2.73M |
|
729
Evergy
EVRG
$19.3B
| $4.27M | 0.02% |
73,037
+62,748
| +610% | +$3.79M |
|
730
Columbia Sportswear
COLM
$2.96B
| $4.26M | 0.02% |
+55,149
| New | +$4.44M |
|
731
Arlo Technologies
ARLO
$1.54B
| $4.26M | 0.02% |
+390,359
| New | +$3.17M |
|
732
Liberty Global Class C
LBTYK
$3.48B
| $4.24M | 0.02% |
238,814
+210,212
| +735% | +$3.92M |
|
733
KB Home
KBH
$3.45B
| $4.23M | 0.02% |
81,771
-375,541
| -82% | -$16.9M |
|
734
Elastic
ESTC
$8.94B
| $4.22M | 0.02% |
65,747
-414
| -0.6% | -$25.9K |
|
735
Concentrix
CNXC
$1.52B
| $4.2M | 0.02% |
+51,978
| New | +$4.86M |
|
736
Phillips Edison & Co
PECO
$5.2B
| $4.2M | 0.02% |
123,107
-48,546
| -28% | -$1.52M |
|
|
CBAY
737
DELISTED
Cymabay Therapeutics
CBAY
| $4.19M | 0.02% |
382,472
-261,340
| -41% | -$2.43M |
|
|
ODP
738
DELISTED
ODP
ODP
| $4.18M | 0.02% |
89,339
+43,912
| +97% | +$1.89M |
|
|
ONC
739
BeOne Medicines Ltd
ONC
$40.3B
| $4.18M | 0.02% |
23,450
+9,128
| +64% | +$2.1M |
|
740
Brixmor Property Group
BRX
$9.21B
| $4.17M | 0.02% |
189,679
+108,586
| +134% | +$2.27M |
|
741
Ubiquiti
UI
$35.3B
| $4.15M | 0.02% |
23,621
+12,249
| +108% | +$2.47M |
|
742
Antero Midstream
AM
$10.5B
| $4.15M | 0.02% |
+357,378
| New | +$3.8M |
|
743
Aon
AON
$75.7B
| $4.14M | 0.02% |
12,003
+6,338
| +112% | +$2.06M |
|
744
Shoals Technologies Group
SHLS
$1.37B
| $4.13M | 0.02% |
161,612
-208,777
| -56% | -$4.83M |
|
745
MarineMax
HZO
$1.15B
| $4.11M | 0.02% |
120,315
-61,686
| -34% | -$1.82M |
|
746
TORM
TRMD
$3.01B
| $4.07M | 0.02% |
168,631
+43,829
| +35% | +$1.22M |
|
747
Iron Mountain
IRM
$37.7B
| $4.07M | 0.02% |
+71,615
| New | +$3.92M |
|
748
NeoGenomics
NEO
$2.11B
| $4.06M | 0.02% |
252,444
-135,621
| -35% | -$2.23M |
|
749
Viking Therapeutics
VKTX
$3.84B
| $4.05M | 0.02% |
249,724
-145,043
| -37% | -$3.04M |
|
750
Bio-Techne
TECH
$11.2B
| $4.03M | 0.02% |
49,343
-398,720
| -89% | -$32M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.